The Georgia Clinical and Translational Science Alliance (GaCTSA) is a compelling partnership of Emory University, Morehouse School of Medicine, the Georgia Institute of Technology and the University of Georgia, a new academic member adding resources and assets to our CTSA. Also key to GaCTSA are our healthcare partners: Emory Healthcare, Morehouse Healthcare, Children?s Healthcare of Atlanta, the Atlanta VA Medical Center, the Grady Health System, and the Atlanta Community Physicians Network and our translational science partners including the Yerkes National Primate Research Center (located at Emory), the Georgia Research Alliance, Georgia Bio and links to the Prevention Research Centers of the US Centers for Disease Control and Prevention (CDC). Built over the past decade of collaboration, the partners of GaCTSA have forged strong research networks and GaCTSA has become a ?24 hour? home and catalyst for innovative, high quality clinical and translational research with local, national and global impact. The addition of UGA allows the GaCTSA to better engage the large, rural and underserved populations of our state and adds new resources, including: outstanding translational research in glycobiology, infectious diseases, One Health, a new clinical and translational research unit, outstanding programs in Education, a School of Pharmacy; a robust extension service that reaches beyond its original agricultural mission to focus on family health; and the Archway Partnership whose mission is to connect Georgia communities with higher education resources to address critical, locally identified community needs. In addition to facilitating innovative science, GaCTSA will encourage collaboration, improve quality and efficiencies, reduce barriers to clinical and translational research and accelerate the process of translating biomedical discoveries into clinical applications. Key to the next funding cycle, GaCTSA will emphasize innovative training and workforce development, access to and integration of special and underserved populations, enhanced biomedical informatics support and capabilities, new methods and processes to improve quality and efficiency, enhanced collaboration and engagement and team-based, quality focused predictive science.
The specific aims of GaCTSA reflect the vision and goals of NCATS Advisory Council Working Group and the recommendations of the 2013 IOM review of the CTSA program. The GaCTSA?s specific aims will serve as guiding principles to drive the vision and approach.

Public Health Relevance

Created in response to the NIH CTSA program, the Georgia Clinical & Translational Science Alliance (GaCTSA) serves as a catalyst and incubator for clinical and translational research across Georgia and with regional and national impact. In addition to facilitating innovative science, we will encourage collaboration, improve quality and efficiencies, reduce barriers to clinical and translational research, and accelerate the process of translating biomedical discoveries into clinical applications.

National Institute of Health (NIH)
National Center for Advancing Translational Sciences (NCATS)
Linked Specialized Center Cooperative Agreement (UL1)
Project #
Application #
Study Section
Special Emphasis Panel (ZTR1)
Program Officer
Davis Nagel, Joan
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Emory University
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Umpierrez, Guillermo E; Klonoff, David C (2018) Diabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital. Diabetes Care 41:1579-1589
Reaves, Barbara J; Wallis, Connor; McCoy, Ciaran J et al. (2018) Recognition and killing of Brugia malayi microfilariae by human immune cells is dependent on the parasite sample and is not altered by ivermectin treatment. Int J Parasitol Drugs Drug Resist 8:587-595
Wang, Tiffany; Kraft, Colleen S; Woodworth, Michael H et al. (2018) Fecal Microbiota Transplant for Refractory Clostridium difficile Infection Interrupts 25-Year History of Recurrent Urinary Tract Infections. Open Forum Infect Dis 5:ofy016
Martin, Greg S (2018) The Medical Perspective on a Disease Life Cycle. Sepsis in the Realm of Implementation Science. Am J Respir Crit Care Med 198:1360-1361
Serota, David P; Sexton, Mary Elizabeth; Kraft, Colleen S et al. (2018) Severe Community-Acquired Pneumonia due to Acinetobacter baumannii in North America: Case Report and Review of the Literature. Open Forum Infect Dis 5:ofy044
Mekonnen, A; Collins, J M; Aseffa, A et al. (2018) Prevalence of pulmonary tuberculosis among students in three eastern Ethiopian universities. Int J Tuberc Lung Dis 22:1210-1215
Titanji, Kehmia; Vunnava, Aswani; Foster, Antonina et al. (2018) T-cell receptor activator of nuclear factor-?B ligand/osteoprotegerin imbalance is associated with HIV-induced bone loss in patients with higher CD4+ T-cell counts. AIDS 32:885-894
Goldsmith, David R; Haroon, Ebrahim; Miller, Andrew H et al. (2018) TNF-? and IL-6 are associated with the deficit syndrome and negative symptoms in patients with chronic schizophrenia. Schizophr Res 199:281-284
Patel, Ravi Mangal; Underwood, Mark A (2018) Probiotics and necrotizing enterocolitis. Semin Pediatr Surg 27:39-46
Llewellyn, Nicole; Carter, Dorothy R; Rollins, Latrice et al. (2018) Charting the Publication and Citation Impact of the NIH Clinical and Translational Science Awards (CTSA) Program From 2006 Through 2016. Acad Med 93:1162-1170

Showing the most recent 10 out of 87 publications